CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- EFFECT Other Notice of Effectiveness
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 424B3 Offering Prospectus
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 5,461 shares at an average $7.29 ($39,836)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 1,791 shares at an average $7.28 ($13,036)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 2,115 shares at an average $7.25 ($15,333)
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 722 shares at an average $7.21 ($5,206)
Page 6 of 33 · 660 filings